187 related articles for article (PubMed ID: 32235007)
21. Nonmosaic somatic HIF2A mutations associated with late onset polycythemia-paraganglioma syndrome: Newly recognized subclass of polycythemia-paraganglioma syndrome.
Pang Y; Gupta G; Jha A; Yue X; Wang H; Huynh TT; Li A; Li L; Baker E; Chew E; Feelders RA; Korpershoek E; Zhuang Z; Yang C; Pacak K
Cancer; 2019 Apr; 125(8):1258-1266. PubMed ID: 30644531
[TBL] [Abstract][Full Text] [Related]
22. Mutation analysis of hypoxia-inducible factors HIF1A and HIF2A in renal cell carcinoma.
Morris MR; Hughes DJ; Tian YM; Ricketts CJ; Lau KW; Gentle D; Shuib S; Serrano-Fernandez P; Lubinski J; Wiesener MS; Pugh CW; Latif F; Ratcliffe PJ; Maher ER
Anticancer Res; 2009 Nov; 29(11):4337-43. PubMed ID: 20032376
[TBL] [Abstract][Full Text] [Related]
23. Involvement of oxygen-sensing pathways in physiologic and pathologic erythropoiesis.
Semenza GL
Blood; 2009 Sep; 114(10):2015-9. PubMed ID: 19494350
[TBL] [Abstract][Full Text] [Related]
24. Hypoxia inducible factor 2 alpha inhibits hepatocellular carcinoma growth through the transcription factor dimerization partner 3/ E2F transcription factor 1-dependent apoptotic pathway.
Sun HX; Xu Y; Yang XR; Wang WM; Bai H; Shi RY; Nayar SK; Devbhandari RP; He YZ; Zhu QF; Sun YF; Hu B; Khan M; Anders RA; Fan J
Hepatology; 2013 Mar; 57(3):1088-97. PubMed ID: 23212661
[TBL] [Abstract][Full Text] [Related]
25. Heritable disorders of oxygen sensing.
Semenza GL
Am J Med Genet A; 2021 Nov; 185(11):3334-3339. PubMed ID: 34655169
[TBL] [Abstract][Full Text] [Related]
26. New syndrome of paraganglioma and somatostatinoma associated with polycythemia.
Pacak K; Jochmanova I; Prodanov T; Yang C; Merino MJ; Fojo T; Prchal JT; Tischler AS; Lechan RM; Zhuang Z
J Clin Oncol; 2013 May; 31(13):1690-8. PubMed ID: 23509317
[TBL] [Abstract][Full Text] [Related]
27. Germ-line PHD1 and PHD2 mutations detected in patients with pheochromocytoma/paraganglioma-polycythemia.
Yang C; Zhuang Z; Fliedner SM; Shankavaram U; Sun MG; Bullova P; Zhu R; Elkahloun AG; Kourlas PJ; Merino M; Kebebew E; Pacak K
J Mol Med (Berl); 2015 Jan; 93(1):93-104. PubMed ID: 25263965
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis B virus induces hypoxia-inducible factor-2α expression through hepatitis B virus X protein.
Hu JL; Liu LP; Yang SL; Fang X; Wen L; Ren QG; Yu C
Oncol Rep; 2016 Mar; 35(3):1443-8. PubMed ID: 26647960
[TBL] [Abstract][Full Text] [Related]
29. Cross talk between oxidative stress and hypoxia via thioredoxin and HIF-2α drives metastasis of hepatocellular carcinoma.
Cao MQ; You AB; Cui W; Zhang S; Guo ZG; Chen L; Zhu XD; Zhang W; Zhu XL; Guo H; Deng DJ; Sun HC; Zhang T
FASEB J; 2020 Apr; 34(4):5892-5905. PubMed ID: 32157720
[TBL] [Abstract][Full Text] [Related]
30. 2-Methoxyestradiol synergizes with sorafenib to suppress hepatocellular carcinoma by simultaneously dysregulating hypoxia-inducible factor-1 and -2.
Ma L; Li G; Zhu H; Dong X; Zhao D; Jiang X; Li J; Qiao H; Ni S; Sun X
Cancer Lett; 2014 Dec; 355(1):96-105. PubMed ID: 25218350
[TBL] [Abstract][Full Text] [Related]
31. Update on mutations in the HIF: EPO pathway and their role in erythrocytosis.
Lappin TR; Lee FS
Blood Rev; 2019 Sep; 37():100590. PubMed ID: 31350093
[TBL] [Abstract][Full Text] [Related]
32. Familial erythrocytosis arising from a gain-of-function mutation in the HIF2A gene of the oxygen sensing pathway.
Percy MJ
Ulster Med J; 2008 May; 77(2):86-8. PubMed ID: 18711622
[TBL] [Abstract][Full Text] [Related]
33. The Genomics and Genetics of Oxygen Homeostasis.
Semenza GL
Annu Rev Genomics Hum Genet; 2020 Aug; 21():183-204. PubMed ID: 32255719
[TBL] [Abstract][Full Text] [Related]
34. Effects of hypoxia-inducible factor-1α and hypoxia-inducible factor-2α overexpression on hepatocellular carcinoma survival: A systematic review with meta-analysis.
Ding ZN; Dong ZR; Chen ZQ; Yang YF; Yan LJ; Li HC; Liu KX; Yao CY; Yan YC; Yang CC; Li T
J Gastroenterol Hepatol; 2021 Jun; 36(6):1487-1496. PubMed ID: 33393670
[TBL] [Abstract][Full Text] [Related]
35. A novel biological function of soluble biglycan: Induction of erythropoietin production and polycythemia.
Frey H; Moreth K; Hsieh LT; Zeng-Brouwers J; Rathkolb B; Fuchs H; Gailus-Durner V; Iozzo RV; de Angelis MH; Schaefer L
Glycoconj J; 2017 Jun; 34(3):393-404. PubMed ID: 27600268
[TBL] [Abstract][Full Text] [Related]
36. VHL gene methylation contributes to excessive erythrocytosis in chronic mountain sickness rat model by upregulating the HIF-2α/EPO pathway.
Yang M; Zhu M; Song K; Wuren T; Yan J; Ge RL; Ji L; Cui S
Life Sci; 2021 Feb; 266():118873. PubMed ID: 33309718
[TBL] [Abstract][Full Text] [Related]
37. A Somatic HIF2α Mutation-Induced Multiple and Recurrent Pheochromocytoma/Paraganglioma with Polycythemia: Clinical Study with Literature Review.
Liu Q; Wang Y; Tong D; Liu G; Yuan W; Zhang J; Ye J; Zhang Y; Yuan G; Feng Q; Zhang D; Jiang J
Endocr Pathol; 2017 Mar; 28(1):75-82. PubMed ID: 28116635
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic inhibition of HIF-2α reverses polycythemia and pulmonary hypertension in murine models of human diseases.
Ghosh MC; Zhang DL; Ollivierre WH; Noguchi A; Springer DA; Linehan WM; Rouault TA
Blood; 2021 May; 137(18):2509-2519. PubMed ID: 33512384
[TBL] [Abstract][Full Text] [Related]
39. Zebrafish mutants in the von Hippel-Lindau tumor suppressor display a hypoxic response and recapitulate key aspects of Chuvash polycythemia.
van Rooijen E; Voest EE; Logister I; Korving J; Schwerte T; Schulte-Merker S; Giles RH; van Eeden FJ
Blood; 2009 Jun; 113(25):6449-60. PubMed ID: 19304954
[TBL] [Abstract][Full Text] [Related]
40. The correlation of expression levels of HIF-1α and HIF-2α in hepatocellular carcinoma with capsular invasion, portal vein tumor thrombi and patients' clinical outcome.
Yang SL; Liu LP; Jiang JX; Xiong ZF; He QJ; Wu C
Jpn J Clin Oncol; 2014 Feb; 44(2):159-67. PubMed ID: 24374892
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
